Immersion oil is commonly referred to as pellucid oils having specific optional and viscosity features suitable for microscopy. Refractive index of immersion oil is closer as compared to that of glass and does not refract the light focused on to the item being examined. Hence, light beam is completely focused on to the object which is examined opposed to the beams of light scattering through air.
Global Defoamers Market is Expected to Grow at 4.8% by 2033. Defoamers, also known as antifoaming agents are chemicals that obstructs foam to develop during various industrial processes. They possess surface-active properties and do not dissolve in a foaming medium.
Sodium Chlorite is a white and odorless powder that is used to produce chlorine dioxide. This chlorine dioxide mainly finds application in textiles, bleaching, and pulp along with water purification. One of the main property of chlorine dioxide is its destruction capability of specific pathogenic bacteria while at the same time being useful for intestinal bacteria.
The American College of Obstetricians and Gynecologists states that around 5%-25% pregnant women experience postpartum depression in America. This growing prevalence primarily contribute to the lucrativeness of this market.
The global hypercalcemia treatment market will reach US$ 33,854.7 Mn by 2033 from US$ 13,628.9 Mn in 2021, growing at a CAGR of 10.7% during the forecast period from 2025 to 2033. Hypercalcemia is a condition characterized by elevated levels of serum calcium ranging above 2.6 mmol/L.
Anti-inflammatory therapeutics market expected to reach by US$ 186.1 Bn by 2033 with CAGR of 8.5% during the forecast period from 2025 to 2033. Biologics and immune selective anti-inflammatory derivatives (ImSAIDs) are the promising drugs classes playing major role in the market.
The global seborrheic keratosis (SK) treatment expected to reach US$ 1,320.8 Mn by 2026. Growing preference for cosmetic and aesthetic quotient and high prevalence of seborrheic keratosis are observed to be the key factors driving the seborrheic keratosis treatment market. This market is further characterized by the presence of a multitude of players operating in various treatment modules such as laser, cryosurgery, surgical removal etc. In addition, with promising topical candidates in the pipeline, the seborrheic keratosis treatment market will witness a boost in future growth.
Ultra-low temperature freezers (ULT freezers) are among the most crucial equipment used in healthcare sector to preserve biological samples, drugs, pathogens and others. ULT freezers are designed to operate between -460C to -860C. Thus, ultra-low temperature freezers have become highly popular in medical and R&D sectors to effectively preserve drugs, body organs and blood samples among others. Rising incidences of cancer and other infectious diseases is one of the prominent factors stimulating the market growth.
The incidence of radiation toxicity is on a rise with increase in treatment and diagnosis of various diseases using radiation therapy and nuclear medicine, thus driving the overall market growth. Cancer treatment predominantly utilizes radiation therapy to treat tumours and cancerous cells. Growing prevalence of cancer thus increases the rate of radiation therapy indicating growing risk of radiation toxicity.
The advent of the Internet has made it extremely easy to place order for goods online. This has resulted in an exponential rise in the volume of parcels and packages thereby creating the need for efficient solutions to sort these parcels in order to deliver them to the customers. The ability to correctly and efficiently sort a complete product range that too in a required timeframe without any manual intervention is often one of the greatest challenges faced by depots.
The drugs by therapeutic area market covers pharmaceutical products classified according to the diseases and medical conditions they are designed to treat. Major therapeutic areas include oncology, cardiovascular diseases, diabetes and other metabolic disorders, neurological conditions, infectious diseases, respiratory disorders, immunology, gastrointestinal diseases, dermatology, ophthalmology, women’s health and rare diseases. The category includes prescription drugs, generic medicines, biologics, biosimilars, vaccines and advanced therapies.
The wider global pharmaceutical market provides an appropriate benchmark for evaluating growth across therapeutic drug categories. One current industry estimate projects the pharmaceutical market to increase from approximately USD 1.88 trillion in 2026 to USD 3.22 trillion by 2035, representing a compound annual growth rate of 6.15%. North America held the largest regional share in 2025, while Asia-Pacific is expected to demonstrate notable growth through 2035.
Market growth is being supported by the increasing prevalence of chronic and age-related diseases. Rising cases of cancer, diabetes, cardiovascular disorders, arthritis, respiratory diseases and neurological conditions are creating sustained demand for effective treatments. Population ageing, lifestyle changes, urbanization and improved access to diagnosis are further expanding the number of patients receiving long-term therapy.
Oncology remains an important area for pharmaceutical research and commercial investment. Development activity includes targeted therapies, immune checkpoint inhibitors, antibody-drug conjugates, cell therapies and personalized cancer treatments. Diabetes and obesity drugs are also recording strong demand, supported by the wider use of GLP-1 and other metabolic treatments. Neurology research is expanding across Alzheimer’s disease, Parkinson’s disease, epilepsy and mental health conditions.
Biologic drugs and biosimilars represent major market trends. Biologics are increasingly used to treat cancer, autoimmune diseases and rare disorders, while biosimilars can improve access after reference-product patent expiry. Pharmaceutical companies are also developing gene therapies, RNA-based medicines and other advanced treatments for conditions with limited existing options.
Precision medicine is influencing drug development across multiple therapeutic areas. Biomarkers, genomic testing and companion diagnostics help identify patients who are more likely to respond to specific medicines. Artificial intelligence is also being used for target identification, clinical-trial planning and analysis of real-world treatment data.
Market expansion may be restrained by high research costs, lengthy clinical development, regulatory uncertainty and drug-pricing pressure. Patent expirations can reduce revenue for branded products, while safety concerns or unsuccessful clinical trials may delay commercial launches. Access and reimbursement remain major challenges for expensive biologics and advanced therapies.
Acute Market Reports provides therapeutic-area drug research covering product classes, disease indications, routes of administration, distribution channels, company pipelines, competitive conditions and regional opportunities. These reports help pharmaceutical companies, investors, healthcare providers and distributors evaluate treatment demand and growth prospects through 2035.